# Know Tau Platform: Insights on Alzheimer's Disease and Related Pathologies
Keywords: Alzheimer's disease, tau pathology, biomarkers, extracellular vesicles, plasma tau, clinical trials, tau propagation, tau modification, Alzheimer's biomarkers, tau aggregation

> This platform provides educational insights into Alzheimer's disease and tau pathology through expert perspectives, highlighting recent research and developments from major conferences.

## Details
- [Tau types, propagation, and modification in AD pathology](#): Dr. Ottavio Arancio discusses presentations on tau's role in Alzheimer's disease, including neuronal excitability, molecular landscapes, and epigenetic influences.
- [Involvement of brain extracellular vesicles in tau pathology spread](#): Dr. Tsuneya Ikezu highlights research on extracellular vesicles and their contribution to tau pathology in Alzheimer's disease.
- [Plasma-based biomarkers and AD pathology](#): Dr. Gemma Salvadó reviews studies on plasma biomarkers predicting amyloid and tau pathology.
- [Performance of plasma p-tau217 in an African American population](#): Dr. Carey Gleason shares insights into the diagnostic performance of plasma p-tau217 in diverse populations.
- [Diagnostic accuracy of plasma p-tau217](#): Dr. Nicholas Ashton evaluates plasma p-tau217's reliability in Alzheimer's diagnosis.
- [Blood-based biomarkers in primary and secondary care](#): Dr. Oskar Hansson discusses the application of blood biomarkers in clinical settings.
- [A potential screening approach for patients with early AD](#): Dr. Michael Schöll explores screening methods for early Alzheimer's detection.
- [The potential role of p-tau217 in clinical trials](#): Dr. Bjørn-Eivind Kirsebom examines p-tau217's utility in Alzheimer's clinical trials.
- [Plasma tau biomarkers in research and clinical practice](#): Dr. Suzanne Schindler reviews research on plasma tau biomarkers and their clinical implications.
- [Plasma tau biomarkers in Alzheimer’s disease](#): Dr. Lawren VandeVrede provides perspectives on tau biomarkers presented at AAIC 2024.
- [The spreading of tau in Alzheimer’s disease](#): Dr. Armen Moughamian discusses tau propagation in Alzheimer's disease.
- [The potential role of p-tau217 in research and clinical practice](#): Dr. Jonathan Liss explores the clinical and research applications of p-tau217.
- [Tau in different stages of Alzheimer’s disease](#): Dr. Ronald Schwartz reviews tau's role across Alzheimer's disease progression.
- [Blood-based biomarkers in clinical practice](#): Dr. Elizabeth Vassey highlights the use of blood biomarkers in Alzheimer's clinical care.